Macrophages help NK cells to attack tumor cells by stimulatory NKG2D ligand but protect themselves from NK killing by inhibitory ligand Qa-1

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Zhou, Zhixia ^a   Zhang, Cai ^a   Zhang, Jian ^a   Tian, Zhigang ^a,b  

^a SHANDONG UNIVERSITY   (China)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; INTERLEUKIN 15; INTERLEUKIN 18; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN QA1; NATURAL KILLER CELL RECEPTOR NKG2D; POLYINOSINIC POLYCYTIDYLIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL ACTIVATION; CELL INTERACTION; CELL MEDIATED CYTOTOXICITY; CELL PROTECTION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOLYSIS; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; MACROPHAGE; MOLECULAR INTERACTION; MOUSE; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PROTEIN EXPRESSION; TUMOR CELL; TUMOR IMMUNOLOGY;

ANIMALS; CELL LINE; CELLS, CULTURED; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNITY, INNATE; INTERFERON-BETA; INTERLEUKIN-15; INTERLEUKIN-18; KILLER CELLS, NATURAL; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K;

EID: 84862108520     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036928     Document Type: Article

References (48)

1. McQueen KL, Parham P, (2002) Variable receptors controlling activation and inhibition of NK cells. Curr Opin Immunol 14: 615-621.
2. Moretta L, Bottino C, Pende D, Castriconi R, Mingari MC, et al. (2006) Surface NK receptors and their ligands on tumor cells. Semin Immunol 18: 151-158.
3. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP, (1999) Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 17: 189-220.
4. Biassoni R, Cantoni C, Marras D, Giron-Michel J, Falco M, et al. (2003) Human natural killer cell receptors: insights into their molecular function and structure. J Cell Mol Med 7: 376-387.
5. Vivier E, Biron CA, (2002) Immunology. A pathogen receptor on natural killer cells. Science 296: 1248-1249.
6. Raulet DH, (2004) Interplay of natural killer cells and their receptors with the adaptive immune response. Nat Immunol 5: 996-1002.
7. Raulet DH, (2003) Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 3: 781-790.
8. Watzl C, (2003) The NKG2D receptor and its ligands-recognition beyond the "missing self"? Microbes Infect 5: 31-37.
9. Diefenbach A, Jamieson AM, Liu SD, Shastri N, Raulet DH, (2000) Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat Immunol 1: 119-126.
10. Vance RE, Jamieson AM, Raulet DH, (1999) Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells. J Exp Med 190: 1801-1812.
11. Persson CM, Assarsson E, Vahlne G, Brodin P, Chambers BJ, (2008) Critical role of Qa1b in the protection of mature dendritic cells from NK cell-mediated killing. Scand J Immunol 67: 30-36.
12. Zwirner NW, Fuertes MB, Girart MV, Domaica CI, Rossi LE, (2007) Cytokine-driven regulation of NK cell functions in tumor immunity: role of the MICA-NKG2D system. Cytokine Growth Factor Rev 18: 159-170.
13. Gerosa F, Baldani-Guerra B, Nisii C, Marchesini V, Carra G, et al. (2002) Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med 195: 327-333.
14. Cooper MA, Fehniger TA, Fuchs A, Colonna M, Caligiuri MA, (2004) NK cell and DC interactions. Trends Immunol 25: 47-52.
15. Moretta A, (2002) Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat Rev Immunol 2: 957-964.
16. Walzer T, Dalod M, Robbins SH, Zitvogel L, Vivier E, (2005) Natural-killer cells and dendritic cells: "l'union fait la force". Blood 106: 2252-2258.
17. Taylor PR, Martinez-Pomares L, Stacey M, Lin HH, Brown GD, et al. (2005) Macrophage receptors and immune recognition. Annu Rev Immunol 23: 901-944.
18. Ozinsky A, Underhill DM, Fontenot JD, Hajjar AM, Smith KD, et al. (2000) The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci U S A 97: 13766-13771.
19. Nedvetzki S, Sowinski S, Eagle RA, Harris J, Vely F, et al. (2007) Reciprocal regulation of human natural killer cells and macrophages associated with distinct immune synapses. Blood 109: 3776-3785.
20. Lapaque N, Walzer T, Meresse S, Vivier E, Trowsdale J, (2009) Interactions between human NK cells and macrophages in response to Salmonella infection. J Immunol 182: 4339-4348.
21. Tjwa ET, van Oord GW, Biesta PJ, Boonstra A, Janssen HL, et al. (2012) Restoration of TLR3-activated myeloid dendritic cell activity leads to improved natural killer cell function in chronic hepatitis B. J Virol.
22. Klezovich-Benard M, Corre JP, Jusforgues-Saklani H, Fiole D, Burjek N, et al. (2012) Mechanisms of NK Cell-Macrophage Bacillus anthracis Crosstalk: A Balance between Stimulation by Spores and Differential Disruption by Toxins. PLoS Pathog 8: e1002481.
23. Jiang Q, Wei H, Tian Z, (2008) Poly I:C enhances cycloheximide-induced apoptosis of tumor cells through TLR3 pathway. BMC Cancer 8: 12.
24. Colmenero P, Zhang AL, Qian T, Lu L, Cantor H, et al. (2007) Qa-1(b)-dependent modulation of dendritic cell and NK cell cross-talk in vivo. J Immunol 179: 4608-4615.
25. Salem ML, El-Naggar SA, Kadima A, Gillanders WE, Cole DJ, (2006) The adjuvant effects of the toll-like receptor 3 ligand polyinosinic-cytidylic acid poly (I:C) on antigen-specific CD8+ T cell responses are partially dependent on NK cells with the induction of a beneficial cytokine milieu. Vaccine 24: 5119-5132.
26. Whitmore MM, DeVeer MJ, Edling A, Oates RK, Simons B, et al. (2004) Synergistic activation of innate immunity by double-stranded RNA and CpG DNA promotes enhanced antitumor activity. Cancer Res 64: 5850-5860.
27. Reimer T, Brcic M, Schweizer M, Jungi TW, (2008) poly(I:C) and LPS induce distinct IRF3 and NF-kappaB signaling during type-I IFN and TNF responses in human macrophages. J Leukoc Biol 83: 1249-1257.
28. Wang J, Xu J, Zhang W, Wei H, Tian Z, (2005) TLR3 ligand-induced accumulation of activated splenic natural killer cells into liver. Cell Mol Immunol 2: 449-453.
29. Wang J, Sun R, Wei H, Dong Z, Gao B, et al. (2006) Poly I:C prevents T cell-mediated hepatitis via an NK-dependent mechanism. J Hepatol 44: 446-454.
30. Hamerman JA, Ogasawara K, Lanier LL, (2004) Cutting edge: Toll-like receptor signaling in macrophages induces ligands for the NKG2D receptor. J Immunol 172: 2001-2005.
31. Jinushi M, Takehara T, Kanto T, Tatsumi T, Groh V, et al. (2003) Critical role of MHC class I-related chain A and B expression on IFN-alpha-stimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C virus infection. J Immunol 170: 1249-1256.
32. Jinushi M, Takehara T, Tatsumi T, Kanto T, Groh V, et al. (2003) Autocrine/paracrine IL-15 that is required for type I IFN-mediated dendritic cell expression of MHC class I-related chain A and B is impaired in hepatitis C virus infection. J Immunol 171: 5423-5429.
33. Baratin M, Roetynck S, Lepolard C, Falk C, Sawadogo S, et al. (2005) Natural killer cell and macrophage cooperation in MyD88-dependent innate responses to Plasmodium falciparum. Proc Natl Acad Sci U S A 102: 14747-14752.
34. Elhaik-Goldman S, Kafka D, Yossef R, Hadad U, Elkabets M, et al. (2011) The natural cytotoxicity receptor 1 contribution to early clearance of Streptococcus pneumoniae and to natural killer-macrophage cross talk. PLoS One 6: e23472.
35. Bellora F, Castriconi R, Dondero A, Reggiardo G, Moretta L, et al. (2010) The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes. Proc Natl Acad Sci U S A 107: 21659-21664.
36. Romo N, Magri G, Muntasell A, Heredia G, Baia D, et al. (2011) Natural killer cell-mediated response to human cytomegalovirus-infected macrophages is modulated by their functional polarization. J Leukoc Biol 90: 717-726.
37. Prajeeth CK, Haeberlein S, Sebald H, Schleicher U, Bogdan C, (2011) Leishmania-infected macrophages are targets of NK cell-derived cytokines but not of NK cell cytotoxicity. Infect Immun 79: 2699-2708.
38. Groh V, Wu J, Yee C, Spies T, (2002) Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 419: 734-738.
39. Oppenheim DE, Roberts SJ, Clarke SL, Filler R, Lewis JM, et al. (2005) Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance. Nat Immunol 6: 928-937.
40. Lu L, Ikizawa K, Hu D, Werneck MB, Wucherpfennig KW, et al. (2007) Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway. Immunity 26: 593-604.
41. Ota T, Takeda K, Akiba H, Hayakawa Y, Ogasawara K, et al. (2005) IFN-gamma-mediated negative feedback regulation of NKT-cell function by CD94/NKG2. Blood 106: 184-192.
42. Roberts AI, Lee L, Schwarz E, Groh V, Spies T, et al. (2001) NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment. J Immunol 167: 5527-5530.
43. Zhang C, Zhang J, Niu J, Tian Z, (2008) Interleukin-15 improves cytotoxicity of natural killer cells via up-regulating NKG2D and cytotoxic effector molecule expression as well as STAT1 and ERK1/2 phosphorylation. Cytokine 42: 128-136.
44. Zhang C, Zhang J, Niu J, Zhou Z, Tian Z, (2008) Interleukin-12 improves cytotoxicity of natural killer cells via upregulated expression of NKG2D. Hum Immunol 69: 490-500.
45. Coudert JD, Zimmer J, Tomasello E, Cebecauer M, Colonna M, et al. (2005) Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells. Blood 106: 1711-1717.
46. Zhang C, Zhang J, Sun R, Feng J, Wei H, et al. (2005) Opposing effect of IFNgamma and IFNalpha on expression of NKG2 receptors: negative regulation of IFNgamma on NK cells. Int Immunopharmacol 5: 1057-1067.
47. Wu JD, Higgins LM, Steinle A, Cosman D, Haugk K, et al. (2004) Prevalent expression of the immunostimulatory MHC class I chain-related molecule is counteracted by shedding in prostate cancer. J Clin Invest 114: 560-568.
48. Wang H, Ruan Z, Wang Y, Han J, Fu X, et al. (2008) MHC class I chain-related molecules induced on monocytes by IFN-gamma promote NK cell activation. Mol Immunol 45: 1548-1556.